These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23354308)

  • 1. Degradation of NF-κB, p53 and other regulatory redox-sensitive proteins by thiol-conjugating and -nitrosylating drugs in human tumor cells.
    Paranjpe A; Srivenugopal KS
    Carcinogenesis; 2013 May; 34(5):990-1000. PubMed ID: 23354308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics.
    Yang Y; Kitagaki J; Dai RM; Tsai YC; Lorick KL; Ludwig RL; Pierre SA; Jensen JP; Davydov IV; Oberoi P; Li CC; Kenten JH; Beutler JA; Vousden KH; Weissman AM
    Cancer Res; 2007 Oct; 67(19):9472-81. PubMed ID: 17909057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway.
    Kikuchi H; Ozaki T; Furuya K; Hanamoto T; Nakanishi M; Yamamoto H; Yoshida K; Todo S; Nakagawara A
    Oncogene; 2006 Dec; 25(58):7608-17. PubMed ID: 16953234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells.
    Shao J; Fujiwara T; Kadowaki Y; Fukazawa T; Waku T; Itoshima T; Yamatsuji T; Nishizaki M; Roth JA; Tanaka N
    Oncogene; 2000 Feb; 19(6):726-36. PubMed ID: 10698490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiol antioxidants sensitize malabaricone C induced cancer cell death via reprogramming redox sensitive p53 and NF-κB proteins in vitro and in vivo.
    Tyagi M; Bauri AK; Chattopadhyay S; Patro BS
    Free Radic Biol Med; 2020 Feb; 148():182-199. PubMed ID: 31945496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage.
    Aleyasin H; Cregan SP; Iyirhiaro G; O'Hare MJ; Callaghan SM; Slack RS; Park DS
    J Neurosci; 2004 Mar; 24(12):2963-73. PubMed ID: 15044535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
    Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaB.
    Fujioka S; Schmidt C; Sclabas GM; Li Z; Pelicano H; Peng B; Yao A; Niu J; Zhang W; Evans DB; Abbruzzese JL; Huang P; Chiao PJ
    J Biol Chem; 2004 Jun; 279(26):27549-59. PubMed ID: 15102862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
    Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts.
    Han J; Liu L; Yue X; Chang J; Shi W; Hua Y
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):477-83. PubMed ID: 24060341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor alpha (TNFalpha).
    Yamaguchi T; Kimura J; Miki Y; Yoshida K
    J Biol Chem; 2007 Nov; 282(47):33943-8. PubMed ID: 17897950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular inhibitory effects of Velcade correlate with morphoproteomic expression of phosphorylated-nuclear factor-kappaB and p53 in breast cancer cell lines.
    Lun M; Zhang PL; Siegelmann-Danieli N; Blasick TM; Brown RE
    Ann Clin Lab Sci; 2005; 35(1):15-24. PubMed ID: 15830705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uraemic serum induces dysfunction of vascular endothelial cells: role of ubiquitin-proteasome pathway.
    Feng B; Zhang YQ; Mu J; Yuan FH; Ye ZL; Qi W; Guo YH; Zeng W; Luo ZF
    Exp Physiol; 2011 Aug; 96(8):801-15. PubMed ID: 21602294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways.
    Li Y; Wang LH; Zhang HT; Wang YT; Liu S; Zhou WL; Yuan XZ; Li TY; Wu CF; Yang JY
    J Cell Mol Med; 2018 Jan; 22(1):439-451. PubMed ID: 29148232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53.
    Shinohara T; Miki T; Nishimura N; Nokihara H; Hamada H; Mukaida N; Sone S
    Cancer Res; 2001 Jan; 61(2):673-8. PubMed ID: 11212267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor kappaB activity.
    Pei XH; Nakanishi Y; Takayama K; Bai F; Hara N
    J Biol Chem; 1999 Dec; 274(49):35240-6. PubMed ID: 10575010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation.
    Chen JJ; Chou CW; Chang YF; Chen CC
    J Immunol; 2008 Jun; 180(12):8030-9. PubMed ID: 18523266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
    Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
    J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
    Huang H; Liao Y; Liu N; Hua X; Cai J; Yang C; Long H; Zhao C; Chen X; Lan X; Zang D; Wu J; Li X; Shi X; Wang X; Liu J
    Oncotarget; 2016 Jan; 7(3):2796-808. PubMed ID: 26625200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.